Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) specializing in discovery, preclinical, and translational platforms to advance oncology and immuno-oncology. Established in 2006, the company is recognized for its high-quality and extensive preclinical models, including the world's largest commercially available PDX collection and unique tumor organoid services utilizing HUB technology. With 12 facilities across the US, Europe, and APAC, Crown Bioscience partners with clients to evaluate the efficacy and pharmacological profiles of drug candidates, ensuring that patients receive the right treatment at the right time. The company is committed to fostering a diverse and inclusive workplace and adheres to equal opportunity employment practices.